Global Human Primary Hepatocytes Supply, Demand and Key Producers, 2024-2030
The global Human Primary Hepatocytes market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
Human primary hepatocytes have the following advantages: they are consistent with the in vivo environment, the levels of enzymes and cofactors are normal physiological concentrations, and drug metabolism and toxicity can be studied close to physiological conditions. It better retains and maintains the complete shape of liver cells and the metabolic activity of liver cells in vitro, truly reflecting the metabolic situation in the body.
This report studies the global Human Primary Hepatocytes demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Primary Hepatocytes, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Primary Hepatocytes that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Primary Hepatocytes total market, 2019-2030, (USD Million)
Global Human Primary Hepatocytes total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Human Primary Hepatocytes total market, key domestic companies and share, (USD Million)
Global Human Primary Hepatocytes revenue by player and market share 2019-2024, (USD Million)
Global Human Primary Hepatocytes total market by Type, CAGR, 2019-2030, (USD Million)
Global Human Primary Hepatocytes total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Human Primary Hepatocytes market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Merck KGaA, Lonza, Cell Biologics, Inc., PromoCell GmbH, HemaCare Corporation, ZenBio, Inc., STEMCELL Technologies, Inc. and Corning Incorporated, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Primary Hepatocytes market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Human Primary Hepatocytes Market, By Region:
1. How big is the global Human Primary Hepatocytes market?
2. What is the demand of the global Human Primary Hepatocytes market?
3. What is the year over year growth of the global Human Primary Hepatocytes market?
4. What is the total value of the global Human Primary Hepatocytes market?
5. Who are the major players in the global Human Primary Hepatocytes market?
Human primary hepatocytes have the following advantages: they are consistent with the in vivo environment, the levels of enzymes and cofactors are normal physiological concentrations, and drug metabolism and toxicity can be studied close to physiological conditions. It better retains and maintains the complete shape of liver cells and the metabolic activity of liver cells in vitro, truly reflecting the metabolic situation in the body.
This report studies the global Human Primary Hepatocytes demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Primary Hepatocytes, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Primary Hepatocytes that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Primary Hepatocytes total market, 2019-2030, (USD Million)
Global Human Primary Hepatocytes total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Human Primary Hepatocytes total market, key domestic companies and share, (USD Million)
Global Human Primary Hepatocytes revenue by player and market share 2019-2024, (USD Million)
Global Human Primary Hepatocytes total market by Type, CAGR, 2019-2030, (USD Million)
Global Human Primary Hepatocytes total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Human Primary Hepatocytes market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Merck KGaA, Lonza, Cell Biologics, Inc., PromoCell GmbH, HemaCare Corporation, ZenBio, Inc., STEMCELL Technologies, Inc. and Corning Incorporated, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Primary Hepatocytes market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Human Primary Hepatocytes Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Hepatocyte
- Cytoplasmic Cells
- Hepatic Stellate Cells
- Bile Duct Epithelial Cells
- Islet Cells
- Life Science Research Company
- Research Institute
- Others
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Lonza
- Cell Biologics, Inc.
- PromoCell GmbH
- HemaCare Corporation
- ZenBio, Inc.
- STEMCELL Technologies, Inc.
- Corning Incorporated
- Axol Bioscience Ltd.
- iXCells Biotechnologies
- Neuromics
- BioIVT
- ScienCell Research Laboratories, Inc.
- Creative Bioarray
- BPS Bioscience, Inc.
- AcceGen
- Sekisui XenoTech, LLC
- Biopredic International
1. How big is the global Human Primary Hepatocytes market?
2. What is the demand of the global Human Primary Hepatocytes market?
3. What is the year over year growth of the global Human Primary Hepatocytes market?
4. What is the total value of the global Human Primary Hepatocytes market?
5. Who are the major players in the global Human Primary Hepatocytes market?
1 SUPPLY SUMMARY
1.1 Human Primary Hepatocytes Introduction
1.2 World Human Primary Hepatocytes Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Human Primary Hepatocytes Total Market by Region (by Headquarter Location)
1.3.1 World Human Primary Hepatocytes Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Human Primary Hepatocytes Market Size (2019-2030)
1.3.3 China Human Primary Hepatocytes Market Size (2019-2030)
1.3.4 Europe Human Primary Hepatocytes Market Size (2019-2030)
1.3.5 Japan Human Primary Hepatocytes Market Size (2019-2030)
1.3.6 South Korea Human Primary Hepatocytes Market Size (2019-2030)
1.3.7 ASEAN Human Primary Hepatocytes Market Size (2019-2030)
1.3.8 India Human Primary Hepatocytes Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Primary Hepatocytes Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Primary Hepatocytes Major Market Trends
2 DEMAND SUMMARY
2.1 World Human Primary Hepatocytes Consumption Value (2019-2030)
2.2 World Human Primary Hepatocytes Consumption Value by Region
2.2.1 World Human Primary Hepatocytes Consumption Value by Region (2019-2024)
2.2.2 World Human Primary Hepatocytes Consumption Value Forecast by Region (2025-2030)
2.3 United States Human Primary Hepatocytes Consumption Value (2019-2030)
2.4 China Human Primary Hepatocytes Consumption Value (2019-2030)
2.5 Europe Human Primary Hepatocytes Consumption Value (2019-2030)
2.6 Japan Human Primary Hepatocytes Consumption Value (2019-2030)
2.7 South Korea Human Primary Hepatocytes Consumption Value (2019-2030)
2.8 ASEAN Human Primary Hepatocytes Consumption Value (2019-2030)
2.9 India Human Primary Hepatocytes Consumption Value (2019-2030)
3 WORLD HUMAN PRIMARY HEPATOCYTES COMPANIES COMPETITIVE ANALYSIS
3.1 World Human Primary Hepatocytes Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Human Primary Hepatocytes Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Human Primary Hepatocytes in 2023
3.2.3 Global Concentration Ratios (CR8) for Human Primary Hepatocytes in 2023
3.3 Human Primary Hepatocytes Company Evaluation Quadrant
3.4 Human Primary Hepatocytes Market: Overall Company Footprint Analysis
3.4.1 Human Primary Hepatocytes Market: Region Footprint
3.4.2 Human Primary Hepatocytes Market: Company Product Type Footprint
3.4.3 Human Primary Hepatocytes Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Human Primary Hepatocytes Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Human Primary Hepatocytes Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Human Primary Hepatocytes Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Human Primary Hepatocytes Consumption Value Comparison
4.2.1 United States VS China: Human Primary Hepatocytes Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Human Primary Hepatocytes Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Human Primary Hepatocytes Companies and Market Share, 2019-2024
4.3.1 United States Based Human Primary Hepatocytes Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Human Primary Hepatocytes Revenue, (2019-2024)
4.4 China Based Companies Human Primary Hepatocytes Revenue and Market Share, 2019-2024
4.4.1 China Based Human Primary Hepatocytes Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Human Primary Hepatocytes Revenue, (2019-2024)
4.5 Rest of World Based Human Primary Hepatocytes Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Human Primary Hepatocytes Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Human Primary Hepatocytes Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Primary Hepatocytes Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Hepatocyte
5.2.2 Cytoplasmic Cells
5.2.3 Hepatic Stellate Cells
5.2.4 Bile Duct Epithelial Cells
5.2.5 Islet Cells
5.3 Market Segment by Type
5.3.1 World Human Primary Hepatocytes Market Size by Type (2019-2024)
5.3.2 World Human Primary Hepatocytes Market Size by Type (2025-2030)
5.3.3 World Human Primary Hepatocytes Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Primary Hepatocytes Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Life Science Research Company
6.2.2 Research Institute
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Human Primary Hepatocytes Market Size by Application (2019-2024)
6.3.2 World Human Primary Hepatocytes Market Size by Application (2025-2030)
6.3.3 World Human Primary Hepatocytes Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 Thermo Fisher Scientific, Inc.
7.1.1 Thermo Fisher Scientific, Inc. Details
7.1.2 Thermo Fisher Scientific, Inc. Major Business
7.1.3 Thermo Fisher Scientific, Inc. Human Primary Hepatocytes Product and Services
7.1.4 Thermo Fisher Scientific, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
7.1.6 Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
7.2 Merck KGaA
7.2.1 Merck KGaA Details
7.2.2 Merck KGaA Major Business
7.2.3 Merck KGaA Human Primary Hepatocytes Product and Services
7.2.4 Merck KGaA Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Merck KGaA Recent Developments/Updates
7.2.6 Merck KGaA Competitive Strengths & Weaknesses
7.3 Lonza
7.3.1 Lonza Details
7.3.2 Lonza Major Business
7.3.3 Lonza Human Primary Hepatocytes Product and Services
7.3.4 Lonza Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Lonza Recent Developments/Updates
7.3.6 Lonza Competitive Strengths & Weaknesses
7.4 Cell Biologics, Inc.
7.4.1 Cell Biologics, Inc. Details
7.4.2 Cell Biologics, Inc. Major Business
7.4.3 Cell Biologics, Inc. Human Primary Hepatocytes Product and Services
7.4.4 Cell Biologics, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Cell Biologics, Inc. Recent Developments/Updates
7.4.6 Cell Biologics, Inc. Competitive Strengths & Weaknesses
7.5 PromoCell GmbH
7.5.1 PromoCell GmbH Details
7.5.2 PromoCell GmbH Major Business
7.5.3 PromoCell GmbH Human Primary Hepatocytes Product and Services
7.5.4 PromoCell GmbH Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 PromoCell GmbH Recent Developments/Updates
7.5.6 PromoCell GmbH Competitive Strengths & Weaknesses
7.6 HemaCare Corporation
7.6.1 HemaCare Corporation Details
7.6.2 HemaCare Corporation Major Business
7.6.3 HemaCare Corporation Human Primary Hepatocytes Product and Services
7.6.4 HemaCare Corporation Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 HemaCare Corporation Recent Developments/Updates
7.6.6 HemaCare Corporation Competitive Strengths & Weaknesses
7.7 ZenBio, Inc.
7.7.1 ZenBio, Inc. Details
7.7.2 ZenBio, Inc. Major Business
7.7.3 ZenBio, Inc. Human Primary Hepatocytes Product and Services
7.7.4 ZenBio, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 ZenBio, Inc. Recent Developments/Updates
7.7.6 ZenBio, Inc. Competitive Strengths & Weaknesses
7.8 STEMCELL Technologies, Inc.
7.8.1 STEMCELL Technologies, Inc. Details
7.8.2 STEMCELL Technologies, Inc. Major Business
7.8.3 STEMCELL Technologies, Inc. Human Primary Hepatocytes Product and Services
7.8.4 STEMCELL Technologies, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 STEMCELL Technologies, Inc. Recent Developments/Updates
7.8.6 STEMCELL Technologies, Inc. Competitive Strengths & Weaknesses
7.9 Corning Incorporated
7.9.1 Corning Incorporated Details
7.9.2 Corning Incorporated Major Business
7.9.3 Corning Incorporated Human Primary Hepatocytes Product and Services
7.9.4 Corning Incorporated Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Corning Incorporated Recent Developments/Updates
7.9.6 Corning Incorporated Competitive Strengths & Weaknesses
7.10 Axol Bioscience Ltd.
7.10.1 Axol Bioscience Ltd. Details
7.10.2 Axol Bioscience Ltd. Major Business
7.10.3 Axol Bioscience Ltd. Human Primary Hepatocytes Product and Services
7.10.4 Axol Bioscience Ltd. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Axol Bioscience Ltd. Recent Developments/Updates
7.10.6 Axol Bioscience Ltd. Competitive Strengths & Weaknesses
7.11 iXCells Biotechnologies
7.11.1 iXCells Biotechnologies Details
7.11.2 iXCells Biotechnologies Major Business
7.11.3 iXCells Biotechnologies Human Primary Hepatocytes Product and Services
7.11.4 iXCells Biotechnologies Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 iXCells Biotechnologies Recent Developments/Updates
7.11.6 iXCells Biotechnologies Competitive Strengths & Weaknesses
7.12 Neuromics
7.12.1 Neuromics Details
7.12.2 Neuromics Major Business
7.12.3 Neuromics Human Primary Hepatocytes Product and Services
7.12.4 Neuromics Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Neuromics Recent Developments/Updates
7.12.6 Neuromics Competitive Strengths & Weaknesses
7.13 BioIVT
7.13.1 BioIVT Details
7.13.2 BioIVT Major Business
7.13.3 BioIVT Human Primary Hepatocytes Product and Services
7.13.4 BioIVT Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 BioIVT Recent Developments/Updates
7.13.6 BioIVT Competitive Strengths & Weaknesses
7.14 ScienCell Research Laboratories, Inc.
7.14.1 ScienCell Research Laboratories, Inc. Details
7.14.2 ScienCell Research Laboratories, Inc. Major Business
7.14.3 ScienCell Research Laboratories, Inc. Human Primary Hepatocytes Product and Services
7.14.4 ScienCell Research Laboratories, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 ScienCell Research Laboratories, Inc. Recent Developments/Updates
7.14.6 ScienCell Research Laboratories, Inc. Competitive Strengths & Weaknesses
7.15 Creative Bioarray
7.15.1 Creative Bioarray Details
7.15.2 Creative Bioarray Major Business
7.15.3 Creative Bioarray Human Primary Hepatocytes Product and Services
7.15.4 Creative Bioarray Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 Creative Bioarray Recent Developments/Updates
7.15.6 Creative Bioarray Competitive Strengths & Weaknesses
7.16 BPS Bioscience, Inc.
7.16.1 BPS Bioscience, Inc. Details
7.16.2 BPS Bioscience, Inc. Major Business
7.16.3 BPS Bioscience, Inc. Human Primary Hepatocytes Product and Services
7.16.4 BPS Bioscience, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 BPS Bioscience, Inc. Recent Developments/Updates
7.16.6 BPS Bioscience, Inc. Competitive Strengths & Weaknesses
7.17 AcceGen
7.17.1 AcceGen Details
7.17.2 AcceGen Major Business
7.17.3 AcceGen Human Primary Hepatocytes Product and Services
7.17.4 AcceGen Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 AcceGen Recent Developments/Updates
7.17.6 AcceGen Competitive Strengths & Weaknesses
7.18 Sekisui XenoTech, LLC
7.18.1 Sekisui XenoTech, LLC Details
7.18.2 Sekisui XenoTech, LLC Major Business
7.18.3 Sekisui XenoTech, LLC Human Primary Hepatocytes Product and Services
7.18.4 Sekisui XenoTech, LLC Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 Sekisui XenoTech, LLC Recent Developments/Updates
7.18.6 Sekisui XenoTech, LLC Competitive Strengths & Weaknesses
7.19 Biopredic International
7.19.1 Biopredic International Details
7.19.2 Biopredic International Major Business
7.19.3 Biopredic International Human Primary Hepatocytes Product and Services
7.19.4 Biopredic International Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.19.5 Biopredic International Recent Developments/Updates
7.19.6 Biopredic International Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Human Primary Hepatocytes Industry Chain
8.2 Human Primary Hepatocytes Upstream Analysis
8.3 Human Primary Hepatocytes Midstream Analysis
8.4 Human Primary Hepatocytes Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Human Primary Hepatocytes Introduction
1.2 World Human Primary Hepatocytes Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Human Primary Hepatocytes Total Market by Region (by Headquarter Location)
1.3.1 World Human Primary Hepatocytes Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Human Primary Hepatocytes Market Size (2019-2030)
1.3.3 China Human Primary Hepatocytes Market Size (2019-2030)
1.3.4 Europe Human Primary Hepatocytes Market Size (2019-2030)
1.3.5 Japan Human Primary Hepatocytes Market Size (2019-2030)
1.3.6 South Korea Human Primary Hepatocytes Market Size (2019-2030)
1.3.7 ASEAN Human Primary Hepatocytes Market Size (2019-2030)
1.3.8 India Human Primary Hepatocytes Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Primary Hepatocytes Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Primary Hepatocytes Major Market Trends
2 DEMAND SUMMARY
2.1 World Human Primary Hepatocytes Consumption Value (2019-2030)
2.2 World Human Primary Hepatocytes Consumption Value by Region
2.2.1 World Human Primary Hepatocytes Consumption Value by Region (2019-2024)
2.2.2 World Human Primary Hepatocytes Consumption Value Forecast by Region (2025-2030)
2.3 United States Human Primary Hepatocytes Consumption Value (2019-2030)
2.4 China Human Primary Hepatocytes Consumption Value (2019-2030)
2.5 Europe Human Primary Hepatocytes Consumption Value (2019-2030)
2.6 Japan Human Primary Hepatocytes Consumption Value (2019-2030)
2.7 South Korea Human Primary Hepatocytes Consumption Value (2019-2030)
2.8 ASEAN Human Primary Hepatocytes Consumption Value (2019-2030)
2.9 India Human Primary Hepatocytes Consumption Value (2019-2030)
3 WORLD HUMAN PRIMARY HEPATOCYTES COMPANIES COMPETITIVE ANALYSIS
3.1 World Human Primary Hepatocytes Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Human Primary Hepatocytes Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Human Primary Hepatocytes in 2023
3.2.3 Global Concentration Ratios (CR8) for Human Primary Hepatocytes in 2023
3.3 Human Primary Hepatocytes Company Evaluation Quadrant
3.4 Human Primary Hepatocytes Market: Overall Company Footprint Analysis
3.4.1 Human Primary Hepatocytes Market: Region Footprint
3.4.2 Human Primary Hepatocytes Market: Company Product Type Footprint
3.4.3 Human Primary Hepatocytes Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Human Primary Hepatocytes Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Human Primary Hepatocytes Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Human Primary Hepatocytes Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Human Primary Hepatocytes Consumption Value Comparison
4.2.1 United States VS China: Human Primary Hepatocytes Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Human Primary Hepatocytes Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Human Primary Hepatocytes Companies and Market Share, 2019-2024
4.3.1 United States Based Human Primary Hepatocytes Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Human Primary Hepatocytes Revenue, (2019-2024)
4.4 China Based Companies Human Primary Hepatocytes Revenue and Market Share, 2019-2024
4.4.1 China Based Human Primary Hepatocytes Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Human Primary Hepatocytes Revenue, (2019-2024)
4.5 Rest of World Based Human Primary Hepatocytes Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Human Primary Hepatocytes Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Human Primary Hepatocytes Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Primary Hepatocytes Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Hepatocyte
5.2.2 Cytoplasmic Cells
5.2.3 Hepatic Stellate Cells
5.2.4 Bile Duct Epithelial Cells
5.2.5 Islet Cells
5.3 Market Segment by Type
5.3.1 World Human Primary Hepatocytes Market Size by Type (2019-2024)
5.3.2 World Human Primary Hepatocytes Market Size by Type (2025-2030)
5.3.3 World Human Primary Hepatocytes Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Primary Hepatocytes Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Life Science Research Company
6.2.2 Research Institute
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Human Primary Hepatocytes Market Size by Application (2019-2024)
6.3.2 World Human Primary Hepatocytes Market Size by Application (2025-2030)
6.3.3 World Human Primary Hepatocytes Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 Thermo Fisher Scientific, Inc.
7.1.1 Thermo Fisher Scientific, Inc. Details
7.1.2 Thermo Fisher Scientific, Inc. Major Business
7.1.3 Thermo Fisher Scientific, Inc. Human Primary Hepatocytes Product and Services
7.1.4 Thermo Fisher Scientific, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
7.1.6 Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
7.2 Merck KGaA
7.2.1 Merck KGaA Details
7.2.2 Merck KGaA Major Business
7.2.3 Merck KGaA Human Primary Hepatocytes Product and Services
7.2.4 Merck KGaA Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Merck KGaA Recent Developments/Updates
7.2.6 Merck KGaA Competitive Strengths & Weaknesses
7.3 Lonza
7.3.1 Lonza Details
7.3.2 Lonza Major Business
7.3.3 Lonza Human Primary Hepatocytes Product and Services
7.3.4 Lonza Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Lonza Recent Developments/Updates
7.3.6 Lonza Competitive Strengths & Weaknesses
7.4 Cell Biologics, Inc.
7.4.1 Cell Biologics, Inc. Details
7.4.2 Cell Biologics, Inc. Major Business
7.4.3 Cell Biologics, Inc. Human Primary Hepatocytes Product and Services
7.4.4 Cell Biologics, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Cell Biologics, Inc. Recent Developments/Updates
7.4.6 Cell Biologics, Inc. Competitive Strengths & Weaknesses
7.5 PromoCell GmbH
7.5.1 PromoCell GmbH Details
7.5.2 PromoCell GmbH Major Business
7.5.3 PromoCell GmbH Human Primary Hepatocytes Product and Services
7.5.4 PromoCell GmbH Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 PromoCell GmbH Recent Developments/Updates
7.5.6 PromoCell GmbH Competitive Strengths & Weaknesses
7.6 HemaCare Corporation
7.6.1 HemaCare Corporation Details
7.6.2 HemaCare Corporation Major Business
7.6.3 HemaCare Corporation Human Primary Hepatocytes Product and Services
7.6.4 HemaCare Corporation Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 HemaCare Corporation Recent Developments/Updates
7.6.6 HemaCare Corporation Competitive Strengths & Weaknesses
7.7 ZenBio, Inc.
7.7.1 ZenBio, Inc. Details
7.7.2 ZenBio, Inc. Major Business
7.7.3 ZenBio, Inc. Human Primary Hepatocytes Product and Services
7.7.4 ZenBio, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 ZenBio, Inc. Recent Developments/Updates
7.7.6 ZenBio, Inc. Competitive Strengths & Weaknesses
7.8 STEMCELL Technologies, Inc.
7.8.1 STEMCELL Technologies, Inc. Details
7.8.2 STEMCELL Technologies, Inc. Major Business
7.8.3 STEMCELL Technologies, Inc. Human Primary Hepatocytes Product and Services
7.8.4 STEMCELL Technologies, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 STEMCELL Technologies, Inc. Recent Developments/Updates
7.8.6 STEMCELL Technologies, Inc. Competitive Strengths & Weaknesses
7.9 Corning Incorporated
7.9.1 Corning Incorporated Details
7.9.2 Corning Incorporated Major Business
7.9.3 Corning Incorporated Human Primary Hepatocytes Product and Services
7.9.4 Corning Incorporated Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Corning Incorporated Recent Developments/Updates
7.9.6 Corning Incorporated Competitive Strengths & Weaknesses
7.10 Axol Bioscience Ltd.
7.10.1 Axol Bioscience Ltd. Details
7.10.2 Axol Bioscience Ltd. Major Business
7.10.3 Axol Bioscience Ltd. Human Primary Hepatocytes Product and Services
7.10.4 Axol Bioscience Ltd. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Axol Bioscience Ltd. Recent Developments/Updates
7.10.6 Axol Bioscience Ltd. Competitive Strengths & Weaknesses
7.11 iXCells Biotechnologies
7.11.1 iXCells Biotechnologies Details
7.11.2 iXCells Biotechnologies Major Business
7.11.3 iXCells Biotechnologies Human Primary Hepatocytes Product and Services
7.11.4 iXCells Biotechnologies Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 iXCells Biotechnologies Recent Developments/Updates
7.11.6 iXCells Biotechnologies Competitive Strengths & Weaknesses
7.12 Neuromics
7.12.1 Neuromics Details
7.12.2 Neuromics Major Business
7.12.3 Neuromics Human Primary Hepatocytes Product and Services
7.12.4 Neuromics Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Neuromics Recent Developments/Updates
7.12.6 Neuromics Competitive Strengths & Weaknesses
7.13 BioIVT
7.13.1 BioIVT Details
7.13.2 BioIVT Major Business
7.13.3 BioIVT Human Primary Hepatocytes Product and Services
7.13.4 BioIVT Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 BioIVT Recent Developments/Updates
7.13.6 BioIVT Competitive Strengths & Weaknesses
7.14 ScienCell Research Laboratories, Inc.
7.14.1 ScienCell Research Laboratories, Inc. Details
7.14.2 ScienCell Research Laboratories, Inc. Major Business
7.14.3 ScienCell Research Laboratories, Inc. Human Primary Hepatocytes Product and Services
7.14.4 ScienCell Research Laboratories, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 ScienCell Research Laboratories, Inc. Recent Developments/Updates
7.14.6 ScienCell Research Laboratories, Inc. Competitive Strengths & Weaknesses
7.15 Creative Bioarray
7.15.1 Creative Bioarray Details
7.15.2 Creative Bioarray Major Business
7.15.3 Creative Bioarray Human Primary Hepatocytes Product and Services
7.15.4 Creative Bioarray Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 Creative Bioarray Recent Developments/Updates
7.15.6 Creative Bioarray Competitive Strengths & Weaknesses
7.16 BPS Bioscience, Inc.
7.16.1 BPS Bioscience, Inc. Details
7.16.2 BPS Bioscience, Inc. Major Business
7.16.3 BPS Bioscience, Inc. Human Primary Hepatocytes Product and Services
7.16.4 BPS Bioscience, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 BPS Bioscience, Inc. Recent Developments/Updates
7.16.6 BPS Bioscience, Inc. Competitive Strengths & Weaknesses
7.17 AcceGen
7.17.1 AcceGen Details
7.17.2 AcceGen Major Business
7.17.3 AcceGen Human Primary Hepatocytes Product and Services
7.17.4 AcceGen Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 AcceGen Recent Developments/Updates
7.17.6 AcceGen Competitive Strengths & Weaknesses
7.18 Sekisui XenoTech, LLC
7.18.1 Sekisui XenoTech, LLC Details
7.18.2 Sekisui XenoTech, LLC Major Business
7.18.3 Sekisui XenoTech, LLC Human Primary Hepatocytes Product and Services
7.18.4 Sekisui XenoTech, LLC Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 Sekisui XenoTech, LLC Recent Developments/Updates
7.18.6 Sekisui XenoTech, LLC Competitive Strengths & Weaknesses
7.19 Biopredic International
7.19.1 Biopredic International Details
7.19.2 Biopredic International Major Business
7.19.3 Biopredic International Human Primary Hepatocytes Product and Services
7.19.4 Biopredic International Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024)
7.19.5 Biopredic International Recent Developments/Updates
7.19.6 Biopredic International Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Human Primary Hepatocytes Industry Chain
8.2 Human Primary Hepatocytes Upstream Analysis
8.3 Human Primary Hepatocytes Midstream Analysis
8.4 Human Primary Hepatocytes Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
.
Table 1. World Human Primary Hepatocytes Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Human Primary Hepatocytes Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Human Primary Hepatocytes Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Human Primary Hepatocytes Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Human Primary Hepatocytes Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Human Primary Hepatocytes Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Human Primary Hepatocytes Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Human Primary Hepatocytes Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Human Primary Hepatocytes Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Human Primary Hepatocytes Players in 2023
Table 12. World Human Primary Hepatocytes Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Human Primary Hepatocytes Company Evaluation Quadrant
Table 14. Head Office of Key Human Primary Hepatocytes Player
Table 15. Human Primary Hepatocytes Market: Company Product Type Footprint
Table 16. Human Primary Hepatocytes Market: Company Product Application Footprint
Table 17. Human Primary Hepatocytes Mergers & Acquisitions Activity
Table 18. United States VS China Human Primary Hepatocytes Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Human Primary Hepatocytes Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Human Primary Hepatocytes Companies, Headquarters (States, Country)
Table 21. United States Based Companies Human Primary Hepatocytes Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Human Primary Hepatocytes Revenue Market Share (2019-2024)
Table 23. China Based Human Primary Hepatocytes Companies, Headquarters (Province, Country)
Table 24. China Based Companies Human Primary Hepatocytes Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Human Primary Hepatocytes Revenue Market Share (2019-2024)
Table 26. Rest of World Based Human Primary Hepatocytes Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Human Primary Hepatocytes Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Human Primary Hepatocytes Revenue Market Share (2019-2024)
Table 29. World Human Primary Hepatocytes Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Human Primary Hepatocytes Market Size by Type (2019-2024) & (USD Million)
Table 31. World Human Primary Hepatocytes Market Size by Type (2025-2030) & (USD Million)
Table 32. World Human Primary Hepatocytes Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Human Primary Hepatocytes Market Size by Application (2019-2024) & (USD Million)
Table 34. World Human Primary Hepatocytes Market Size by Application (2025-2030) & (USD Million)
Table 35. Thermo Fisher Scientific, Inc. Basic Information, Area Served and Competitors
Table 36. Thermo Fisher Scientific, Inc. Major Business
Table 37. Thermo Fisher Scientific, Inc. Human Primary Hepatocytes Product and Services
Table 38. Thermo Fisher Scientific, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Thermo Fisher Scientific, Inc. Recent Developments/Updates
Table 40. Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
Table 41. Merck KGaA Basic Information, Area Served and Competitors
Table 42. Merck KGaA Major Business
Table 43. Merck KGaA Human Primary Hepatocytes Product and Services
Table 44. Merck KGaA Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Merck KGaA Recent Developments/Updates
Table 46. Merck KGaA Competitive Strengths & Weaknesses
Table 47. Lonza Basic Information, Area Served and Competitors
Table 48. Lonza Major Business
Table 49. Lonza Human Primary Hepatocytes Product and Services
Table 50. Lonza Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Lonza Recent Developments/Updates
Table 52. Lonza Competitive Strengths & Weaknesses
Table 53. Cell Biologics, Inc. Basic Information, Area Served and Competitors
Table 54. Cell Biologics, Inc. Major Business
Table 55. Cell Biologics, Inc. Human Primary Hepatocytes Product and Services
Table 56. Cell Biologics, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Cell Biologics, Inc. Recent Developments/Updates
Table 58. Cell Biologics, Inc. Competitive Strengths & Weaknesses
Table 59. PromoCell GmbH Basic Information, Area Served and Competitors
Table 60. PromoCell GmbH Major Business
Table 61. PromoCell GmbH Human Primary Hepatocytes Product and Services
Table 62. PromoCell GmbH Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. PromoCell GmbH Recent Developments/Updates
Table 64. PromoCell GmbH Competitive Strengths & Weaknesses
Table 65. HemaCare Corporation Basic Information, Area Served and Competitors
Table 66. HemaCare Corporation Major Business
Table 67. HemaCare Corporation Human Primary Hepatocytes Product and Services
Table 68. HemaCare Corporation Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. HemaCare Corporation Recent Developments/Updates
Table 70. HemaCare Corporation Competitive Strengths & Weaknesses
Table 71. ZenBio, Inc. Basic Information, Area Served and Competitors
Table 72. ZenBio, Inc. Major Business
Table 73. ZenBio, Inc. Human Primary Hepatocytes Product and Services
Table 74. ZenBio, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. ZenBio, Inc. Recent Developments/Updates
Table 76. ZenBio, Inc. Competitive Strengths & Weaknesses
Table 77. STEMCELL Technologies, Inc. Basic Information, Area Served and Competitors
Table 78. STEMCELL Technologies, Inc. Major Business
Table 79. STEMCELL Technologies, Inc. Human Primary Hepatocytes Product and Services
Table 80. STEMCELL Technologies, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. STEMCELL Technologies, Inc. Recent Developments/Updates
Table 82. STEMCELL Technologies, Inc. Competitive Strengths & Weaknesses
Table 83. Corning Incorporated Basic Information, Area Served and Competitors
Table 84. Corning Incorporated Major Business
Table 85. Corning Incorporated Human Primary Hepatocytes Product and Services
Table 86. Corning Incorporated Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Corning Incorporated Recent Developments/Updates
Table 88. Corning Incorporated Competitive Strengths & Weaknesses
Table 89. Axol Bioscience Ltd. Basic Information, Area Served and Competitors
Table 90. Axol Bioscience Ltd. Major Business
Table 91. Axol Bioscience Ltd. Human Primary Hepatocytes Product and Services
Table 92. Axol Bioscience Ltd. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Axol Bioscience Ltd. Recent Developments/Updates
Table 94. Axol Bioscience Ltd. Competitive Strengths & Weaknesses
Table 95. iXCells Biotechnologies Basic Information, Area Served and Competitors
Table 96. iXCells Biotechnologies Major Business
Table 97. iXCells Biotechnologies Human Primary Hepatocytes Product and Services
Table 98. iXCells Biotechnologies Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. iXCells Biotechnologies Recent Developments/Updates
Table 100. iXCells Biotechnologies Competitive Strengths & Weaknesses
Table 101. Neuromics Basic Information, Area Served and Competitors
Table 102. Neuromics Major Business
Table 103. Neuromics Human Primary Hepatocytes Product and Services
Table 104. Neuromics Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Neuromics Recent Developments/Updates
Table 106. Neuromics Competitive Strengths & Weaknesses
Table 107. BioIVT Basic Information, Area Served and Competitors
Table 108. BioIVT Major Business
Table 109. BioIVT Human Primary Hepatocytes Product and Services
Table 110. BioIVT Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. BioIVT Recent Developments/Updates
Table 112. BioIVT Competitive Strengths & Weaknesses
Table 113. ScienCell Research Laboratories, Inc. Basic Information, Area Served and Competitors
Table 114. ScienCell Research Laboratories, Inc. Major Business
Table 115. ScienCell Research Laboratories, Inc. Human Primary Hepatocytes Product and Services
Table 116. ScienCell Research Laboratories, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. ScienCell Research Laboratories, Inc. Recent Developments/Updates
Table 118. ScienCell Research Laboratories, Inc. Competitive Strengths & Weaknesses
Table 119. Creative Bioarray Basic Information, Area Served and Competitors
Table 120. Creative Bioarray Major Business
Table 121. Creative Bioarray Human Primary Hepatocytes Product and Services
Table 122. Creative Bioarray Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. Creative Bioarray Recent Developments/Updates
Table 124. Creative Bioarray Competitive Strengths & Weaknesses
Table 125. BPS Bioscience, Inc. Basic Information, Area Served and Competitors
Table 126. BPS Bioscience, Inc. Major Business
Table 127. BPS Bioscience, Inc. Human Primary Hepatocytes Product and Services
Table 128. BPS Bioscience, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. BPS Bioscience, Inc. Recent Developments/Updates
Table 130. BPS Bioscience, Inc. Competitive Strengths & Weaknesses
Table 131. AcceGen Basic Information, Area Served and Competitors
Table 132. AcceGen Major Business
Table 133. AcceGen Human Primary Hepatocytes Product and Services
Table 134. AcceGen Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. AcceGen Recent Developments/Updates
Table 136. AcceGen Competitive Strengths & Weaknesses
Table 137. Sekisui XenoTech, LLC Basic Information, Area Served and Competitors
Table 138. Sekisui XenoTech, LLC Major Business
Table 139. Sekisui XenoTech, LLC Human Primary Hepatocytes Product and Services
Table 140. Sekisui XenoTech, LLC Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. Sekisui XenoTech, LLC Recent Developments/Updates
Table 142. Biopredic International Basic Information, Area Served and Competitors
Table 143. Biopredic International Major Business
Table 144. Biopredic International Human Primary Hepatocytes Product and Services
Table 145. Biopredic International Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 146. Global Key Players of Human Primary Hepatocytes Upstream (Raw Materials)
Table 147. Human Primary Hepatocytes Typical Customers
LIST OF FIGURE
.
Figure 1. Human Primary Hepatocytes Picture
Figure 2. World Human Primary Hepatocytes Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Human Primary Hepatocytes Total Market Size (2019-2030) & (USD Million)
Figure 4. World Human Primary Hepatocytes Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Human Primary Hepatocytes Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Human Primary Hepatocytes Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Human Primary Hepatocytes Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Human Primary Hepatocytes Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Human Primary Hepatocytes Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Human Primary Hepatocytes Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Human Primary Hepatocytes Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Human Primary Hepatocytes Revenue (2019-2030) & (USD Million)
Figure 13. Human Primary Hepatocytes Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Human Primary Hepatocytes Consumption Value (2019-2030) & (USD Million)
Figure 16. World Human Primary Hepatocytes Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Human Primary Hepatocytes Consumption Value (2019-2030) & (USD Million)
Figure 18. China Human Primary Hepatocytes Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Human Primary Hepatocytes Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Human Primary Hepatocytes Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Human Primary Hepatocytes Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Human Primary Hepatocytes Consumption Value (2019-2030) & (USD Million)
Figure 23. India Human Primary Hepatocytes Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Human Primary Hepatocytes by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Human Primary Hepatocytes Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Human Primary Hepatocytes Markets in 2023
Figure 27. United States VS China: Human Primary Hepatocytes Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Human Primary Hepatocytes Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Human Primary Hepatocytes Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Human Primary Hepatocytes Market Size Market Share by Type in 2023
Figure 31. Hepatocyte
Figure 32. Cytoplasmic Cells
Figure 33. Hepatic Stellate Cells
Figure 34. Bile Duct Epithelial Cells
Figure 35. Islet Cells
Figure 36. World Human Primary Hepatocytes Market Size Market Share by Type (2019-2030)
Figure 37. World Human Primary Hepatocytes Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 38. World Human Primary Hepatocytes Market Size Market Share by Application in 2023
Figure 39. Life Science Research Company
Figure 40. Research Institute
Figure 41. Others
Figure 42. Human Primary Hepatocytes Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
.
Table 1. World Human Primary Hepatocytes Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Human Primary Hepatocytes Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Human Primary Hepatocytes Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Human Primary Hepatocytes Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Human Primary Hepatocytes Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Human Primary Hepatocytes Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Human Primary Hepatocytes Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Human Primary Hepatocytes Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Human Primary Hepatocytes Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Human Primary Hepatocytes Players in 2023
Table 12. World Human Primary Hepatocytes Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Human Primary Hepatocytes Company Evaluation Quadrant
Table 14. Head Office of Key Human Primary Hepatocytes Player
Table 15. Human Primary Hepatocytes Market: Company Product Type Footprint
Table 16. Human Primary Hepatocytes Market: Company Product Application Footprint
Table 17. Human Primary Hepatocytes Mergers & Acquisitions Activity
Table 18. United States VS China Human Primary Hepatocytes Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Human Primary Hepatocytes Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Human Primary Hepatocytes Companies, Headquarters (States, Country)
Table 21. United States Based Companies Human Primary Hepatocytes Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Human Primary Hepatocytes Revenue Market Share (2019-2024)
Table 23. China Based Human Primary Hepatocytes Companies, Headquarters (Province, Country)
Table 24. China Based Companies Human Primary Hepatocytes Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Human Primary Hepatocytes Revenue Market Share (2019-2024)
Table 26. Rest of World Based Human Primary Hepatocytes Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Human Primary Hepatocytes Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Human Primary Hepatocytes Revenue Market Share (2019-2024)
Table 29. World Human Primary Hepatocytes Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Human Primary Hepatocytes Market Size by Type (2019-2024) & (USD Million)
Table 31. World Human Primary Hepatocytes Market Size by Type (2025-2030) & (USD Million)
Table 32. World Human Primary Hepatocytes Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Human Primary Hepatocytes Market Size by Application (2019-2024) & (USD Million)
Table 34. World Human Primary Hepatocytes Market Size by Application (2025-2030) & (USD Million)
Table 35. Thermo Fisher Scientific, Inc. Basic Information, Area Served and Competitors
Table 36. Thermo Fisher Scientific, Inc. Major Business
Table 37. Thermo Fisher Scientific, Inc. Human Primary Hepatocytes Product and Services
Table 38. Thermo Fisher Scientific, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Thermo Fisher Scientific, Inc. Recent Developments/Updates
Table 40. Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
Table 41. Merck KGaA Basic Information, Area Served and Competitors
Table 42. Merck KGaA Major Business
Table 43. Merck KGaA Human Primary Hepatocytes Product and Services
Table 44. Merck KGaA Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Merck KGaA Recent Developments/Updates
Table 46. Merck KGaA Competitive Strengths & Weaknesses
Table 47. Lonza Basic Information, Area Served and Competitors
Table 48. Lonza Major Business
Table 49. Lonza Human Primary Hepatocytes Product and Services
Table 50. Lonza Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Lonza Recent Developments/Updates
Table 52. Lonza Competitive Strengths & Weaknesses
Table 53. Cell Biologics, Inc. Basic Information, Area Served and Competitors
Table 54. Cell Biologics, Inc. Major Business
Table 55. Cell Biologics, Inc. Human Primary Hepatocytes Product and Services
Table 56. Cell Biologics, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Cell Biologics, Inc. Recent Developments/Updates
Table 58. Cell Biologics, Inc. Competitive Strengths & Weaknesses
Table 59. PromoCell GmbH Basic Information, Area Served and Competitors
Table 60. PromoCell GmbH Major Business
Table 61. PromoCell GmbH Human Primary Hepatocytes Product and Services
Table 62. PromoCell GmbH Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. PromoCell GmbH Recent Developments/Updates
Table 64. PromoCell GmbH Competitive Strengths & Weaknesses
Table 65. HemaCare Corporation Basic Information, Area Served and Competitors
Table 66. HemaCare Corporation Major Business
Table 67. HemaCare Corporation Human Primary Hepatocytes Product and Services
Table 68. HemaCare Corporation Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. HemaCare Corporation Recent Developments/Updates
Table 70. HemaCare Corporation Competitive Strengths & Weaknesses
Table 71. ZenBio, Inc. Basic Information, Area Served and Competitors
Table 72. ZenBio, Inc. Major Business
Table 73. ZenBio, Inc. Human Primary Hepatocytes Product and Services
Table 74. ZenBio, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. ZenBio, Inc. Recent Developments/Updates
Table 76. ZenBio, Inc. Competitive Strengths & Weaknesses
Table 77. STEMCELL Technologies, Inc. Basic Information, Area Served and Competitors
Table 78. STEMCELL Technologies, Inc. Major Business
Table 79. STEMCELL Technologies, Inc. Human Primary Hepatocytes Product and Services
Table 80. STEMCELL Technologies, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. STEMCELL Technologies, Inc. Recent Developments/Updates
Table 82. STEMCELL Technologies, Inc. Competitive Strengths & Weaknesses
Table 83. Corning Incorporated Basic Information, Area Served and Competitors
Table 84. Corning Incorporated Major Business
Table 85. Corning Incorporated Human Primary Hepatocytes Product and Services
Table 86. Corning Incorporated Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Corning Incorporated Recent Developments/Updates
Table 88. Corning Incorporated Competitive Strengths & Weaknesses
Table 89. Axol Bioscience Ltd. Basic Information, Area Served and Competitors
Table 90. Axol Bioscience Ltd. Major Business
Table 91. Axol Bioscience Ltd. Human Primary Hepatocytes Product and Services
Table 92. Axol Bioscience Ltd. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Axol Bioscience Ltd. Recent Developments/Updates
Table 94. Axol Bioscience Ltd. Competitive Strengths & Weaknesses
Table 95. iXCells Biotechnologies Basic Information, Area Served and Competitors
Table 96. iXCells Biotechnologies Major Business
Table 97. iXCells Biotechnologies Human Primary Hepatocytes Product and Services
Table 98. iXCells Biotechnologies Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. iXCells Biotechnologies Recent Developments/Updates
Table 100. iXCells Biotechnologies Competitive Strengths & Weaknesses
Table 101. Neuromics Basic Information, Area Served and Competitors
Table 102. Neuromics Major Business
Table 103. Neuromics Human Primary Hepatocytes Product and Services
Table 104. Neuromics Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Neuromics Recent Developments/Updates
Table 106. Neuromics Competitive Strengths & Weaknesses
Table 107. BioIVT Basic Information, Area Served and Competitors
Table 108. BioIVT Major Business
Table 109. BioIVT Human Primary Hepatocytes Product and Services
Table 110. BioIVT Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. BioIVT Recent Developments/Updates
Table 112. BioIVT Competitive Strengths & Weaknesses
Table 113. ScienCell Research Laboratories, Inc. Basic Information, Area Served and Competitors
Table 114. ScienCell Research Laboratories, Inc. Major Business
Table 115. ScienCell Research Laboratories, Inc. Human Primary Hepatocytes Product and Services
Table 116. ScienCell Research Laboratories, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. ScienCell Research Laboratories, Inc. Recent Developments/Updates
Table 118. ScienCell Research Laboratories, Inc. Competitive Strengths & Weaknesses
Table 119. Creative Bioarray Basic Information, Area Served and Competitors
Table 120. Creative Bioarray Major Business
Table 121. Creative Bioarray Human Primary Hepatocytes Product and Services
Table 122. Creative Bioarray Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. Creative Bioarray Recent Developments/Updates
Table 124. Creative Bioarray Competitive Strengths & Weaknesses
Table 125. BPS Bioscience, Inc. Basic Information, Area Served and Competitors
Table 126. BPS Bioscience, Inc. Major Business
Table 127. BPS Bioscience, Inc. Human Primary Hepatocytes Product and Services
Table 128. BPS Bioscience, Inc. Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. BPS Bioscience, Inc. Recent Developments/Updates
Table 130. BPS Bioscience, Inc. Competitive Strengths & Weaknesses
Table 131. AcceGen Basic Information, Area Served and Competitors
Table 132. AcceGen Major Business
Table 133. AcceGen Human Primary Hepatocytes Product and Services
Table 134. AcceGen Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. AcceGen Recent Developments/Updates
Table 136. AcceGen Competitive Strengths & Weaknesses
Table 137. Sekisui XenoTech, LLC Basic Information, Area Served and Competitors
Table 138. Sekisui XenoTech, LLC Major Business
Table 139. Sekisui XenoTech, LLC Human Primary Hepatocytes Product and Services
Table 140. Sekisui XenoTech, LLC Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. Sekisui XenoTech, LLC Recent Developments/Updates
Table 142. Biopredic International Basic Information, Area Served and Competitors
Table 143. Biopredic International Major Business
Table 144. Biopredic International Human Primary Hepatocytes Product and Services
Table 145. Biopredic International Human Primary Hepatocytes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 146. Global Key Players of Human Primary Hepatocytes Upstream (Raw Materials)
Table 147. Human Primary Hepatocytes Typical Customers
LIST OF FIGURE
.
Figure 1. Human Primary Hepatocytes Picture
Figure 2. World Human Primary Hepatocytes Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Human Primary Hepatocytes Total Market Size (2019-2030) & (USD Million)
Figure 4. World Human Primary Hepatocytes Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Human Primary Hepatocytes Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Human Primary Hepatocytes Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Human Primary Hepatocytes Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Human Primary Hepatocytes Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Human Primary Hepatocytes Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Human Primary Hepatocytes Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Human Primary Hepatocytes Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Human Primary Hepatocytes Revenue (2019-2030) & (USD Million)
Figure 13. Human Primary Hepatocytes Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Human Primary Hepatocytes Consumption Value (2019-2030) & (USD Million)
Figure 16. World Human Primary Hepatocytes Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Human Primary Hepatocytes Consumption Value (2019-2030) & (USD Million)
Figure 18. China Human Primary Hepatocytes Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Human Primary Hepatocytes Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Human Primary Hepatocytes Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Human Primary Hepatocytes Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Human Primary Hepatocytes Consumption Value (2019-2030) & (USD Million)
Figure 23. India Human Primary Hepatocytes Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Human Primary Hepatocytes by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Human Primary Hepatocytes Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Human Primary Hepatocytes Markets in 2023
Figure 27. United States VS China: Human Primary Hepatocytes Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Human Primary Hepatocytes Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Human Primary Hepatocytes Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Human Primary Hepatocytes Market Size Market Share by Type in 2023
Figure 31. Hepatocyte
Figure 32. Cytoplasmic Cells
Figure 33. Hepatic Stellate Cells
Figure 34. Bile Duct Epithelial Cells
Figure 35. Islet Cells
Figure 36. World Human Primary Hepatocytes Market Size Market Share by Type (2019-2030)
Figure 37. World Human Primary Hepatocytes Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 38. World Human Primary Hepatocytes Market Size Market Share by Application in 2023
Figure 39. Life Science Research Company
Figure 40. Research Institute
Figure 41. Others
Figure 42. Human Primary Hepatocytes Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
